AtriCure, Inc. (ATRC) is a publicly traded Healthcare sector company. As of September 11, 2026, ATRC trades at $54.29 with a market cap of $2.70B and a P/E ratio of 251.44. ATRC moved +2.37% today. Year to date, ATRC is +34.86%; over the trailing twelve months it is +50.67%. Its 52-week range spans $25.36 to $55.72. Analyst consensus is strong buy with an average price target of $52.86. Rallies surfaces ATRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ATRC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $54.29 |
| Market Cap | $2.70B |
| P/E Ratio | 251.44 |
| EPS | $0.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.72 |
| 52-Week Low | $25.36 |
| Volume | 433.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $569.62M |
| Net Income | $10.55M |
| Gross Margin | 76.30% |
8 analysts cover ATRC: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.86.